NEW YORK, May 30, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Biocatalysis in pharmaceutical manufacturing is being driven by advances in enzyme and genomics technologies that are increasing the breadth of reaction applicability. The environmental benefits of enzymatic catalysis are also a strong influence.
This report examines the benefits and challenges of implementing enzymatic steps in pharmaceutical manufacturing. It covers why enzymes are central to green chemistry and industrial biotechnology. The range of industrial enzymes and sources of innovation are covered, along with numerous case studies of enzymes being successfully employed.
Scope of this research
- Understand why biocatalysis plays a central role in the emerging trend toward green chemistry.
- Appreciate the power of enzymes in controlling the formation of chiral products.
- Learn of the techniques employed to develop non-natural enzymes that are better suited to industrial processes.
- Examine case studies in which enzymes have provided significant benefits during process development and optimization efforts. Identify the likely sources of future advances in developing novel enzymatic catalysis processes.
Research and analysis highlights
Enzymes can replace conventional catalysts in drug manufacturing and give significant gains in terms of reduced raw mater
Copyright©2010 PR Newswire.
All rights reserved